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INTRODUCTION 
 
               Siddha medicine is a system of traditional medicine originating in ancient 
tamilakkam in South India. This system is believed to have originated several centuries ago or 
even since the beginning of the history of mankind. Lord Shiva is the first saint to describe about 
the siddha medicine to “NANDHI DEVAR” 
And Nandi devar passed it to other saints. Agasthiyar is considered the first siddha 
and the guru of all siddhars. 
According to the ancient siddha texts, a human body is made of several elements. It’s 
a microscopic component of universe. 
The elements that form a human body are earth (munn), fire (thee), water (neer), air 
(vayu) and space (akasam). 
Additionally, there are three humors or doshas called the vata, pitta, and kapha. 
It’s all about balancing the three humors 
 VAADHAM 
 PITTHAM 
 KABAM  
Under normal conditions the ratio between vaadham, pittham and kabam are 4:2:1 
respectively                                                                                                                           







Found in our meals daily. Also our body is formed by five elements. 
It is said in the siddhar  song ‘DEGAM PANCHA POODAM’ 
       Siddha system of medicine not only cures the diseases but also increases the immunity 
system. In this system there is an unique method of treating pediatric groups. Since they are the 
pillars of  upcoming  centuries. 
 
          But nowadays there are no joint family system is most of the families so their children 
depend on medicines for smaller problems. They can be cured by siddha medicines without  
harming their body, unlike allopathic medicine for this disease causes drowsiness and many side 
effects. But using herbal medicine will increase the immune system of the body and hence 
prevents further infection to the body. Also, inappropriate use of antibiotics can lead to 
development of antibiotic resistance and can possibly lead to side effects, such as allergic reaction. 
         The ancient siddha medical system can handle diseases purely on herbs. The combinational 
blend of herbs acts in synergy to subside the infection with its own natural antibiotics. 
         The main reason for most of the people choosing ethic medicines like siddha for handling 
cold and cough is due to its simplicity and without side effects. The Indian medicine system of 
siddha handles cold and cough with simple spices at home or by easily available herbs and easily 
preparable at home. 
 
         The signs and symptoms of Neer kana Maantham mentioned in siddha paediatric book-bala 
vagadam may be correlated with acute naso pharyngitis in modern disease of classification .So I 
considered to evaluate a mixed herbal formulation “Oma kudineer” mentioned in balavagadam 
for the treatment of Neer kana Maantham. 
  









AIM AND OBJECTIVE  
AIM AND OBJECTIVE 
 
        AIM: 
       The aim of study is to evaluate the disease NEER KANA MAANTHAM [Acute Naso 
Pharyngitis] both clinically and experimentally with trial drug OMA KUDINEER. 
 
 OBJECTIVE: 
 To review the literature of the disease Neer Kana Maantham in Siddha and Modern 
Medicine aspect.  
 To compare the etiology, incidence, clinical features, treatment, prognosis and 
complication of Neer  Kana Maantham with Acute naso  pharyngitis in Modern science. 
 To Know the predominance of disease age, sex climate, family history and socio 
economic status are considered. 
 To study the Neer Kana Maantham on basis of siddha parameters such as dearanged  
Mukkuttram ,  poripulangal ,  ezhuudarkattukal and envagai Thervugal. 
 To have the clinical trial of Neer Kana Maantham with trial medicine   
OMA KUDINEER in Govt. Siddha .Medical. College & Hospital, Chennai-106 
 
TO EVALUATE: 
a. Phyto- chemical screening 
b. Physio-chemical screening 
c. Anti -microbial  
d. Anti -inflammatory 
e. Toxicological analysis (Acute) 
f. Pharmacological studies 
g. Bio-statistical analysis of trial drug 
 









REVIEW OF SIDDHA 








SIDDHA ASPECT  
                             SIDDHA LITERATURE   REVIEW 
                                              மாந்தம் 
 
வேறு பெயர்கள் 




 மந்த இயல்பு உளடயது மாந்தம் எனப்ெடும். 
 மாந்தம் என்ெது உருே நிளலயில் உடல்  நிளலயில் மந்தம். 
 அருே நிளலயில் அகக்கருேிகைாகிய மனம், புத்தி, சித்தம், அகங்காரம் அகிய 
அளனத்து அந்தக்கரணங்கைிலும் மந்தம் என குழந்ளத மருத்துேத்தில் 
கூறப்ெட்டுள்ைாது. 
 உண்ட உணவு பசரியாமல் ேயிற்றில் புைித்து ேயிறு உப்ெி இளரந்து மந்தத்ளத 
உண்டாக்கி ோந்திளயயும் கழிச்சளலயும்  உண்டாக்கி துன்ெத்ளதயும்  ஏற்ெடுத்தும்  
வநாய் என ெிள்ளைப்ெிணி மருத்துேதில் குறிப்ெிடப்ெட்டுள்ைது 
 
வநாய் ேரும் ெ௫ேம்: 
 இந்வநாய் தாலப்ெருேம், சப்ொணிப்ெருேம், முத்தப்ெருேம், 
ேருளகப்ெருேங்கைில் உண்டாக்ககூடிய வநாய்கைாகும். 
 குழந்ளதயின் முதலாண்டிலிருந்து மூன்று ஆண்டுகள் ேளரத் பதாடரும்   என 
குழந்ளத மருத்துேம் மற்றும் தன்ேந்திரி குழந்ளத    ோகடத்தில் உள்ைாது 
 இந்வநாய் 3 மாதம் முதல் 12 ேயது ேளர ேரக்கூடியது. 
 ொல் மட்டும்  குடிக்கும் ெருேம் , ொலும்  வசாறும் உண்ணும் ெருேம், வசாறும் 
மட்டும்  உண்ணும் ெருேம் ஆகிய முன்று ெருேங்கைில் மாந்தம் ஏற்ெடும் என 
ெிள்ளைப்ெிணி மருத்துேத்தில் குறிப்ெிடப்ெட்டுள்ைது. 
ந ோய் வரும் ேழி: 
 குழந்ளத ெிறந்த ஒரு ஆண்டிற்குள் நீர் நிளலகைில் ெழுத்து உதிர்ந்த சருகுகள் 
ேிழுந்து அழுகியிருக்கும்  நீளரக்குடிப்ெதாலும். 
  எருளமப்ொல் ,புைித்த எருளம வமார், எருளம பநய்,ோளழப்ெழம்,  மாம்ெழம், 
வதாங்காய், இைநீர், கடளல, பேல்லம், காட்டுத்துேளர, பமாச்ளசக்பகாட்ளட,  
புைியங்பகாட்ளட, ெருப்பு,மாேினாற் பசய்யப்ெட்ட பொருள்கள்,  
அதிரசம், ோயுப்பொருட்கள் ,வசாறு இளேகளை அதிகமாக உண்ொடதாலும் 
மாந்தவநாய் உண்டாம் என குழந்தை மருத்துவம் குறிப்பிடுகிறது. 
 ொகற்காய்கள்,ஊன்,பெரிய உளுளேமீன்,ோளைமீன்,ென்றி, ேரால் மீன், 
பகாண்ளடமீன், இளேகளை உண்ொதலும் மாந்த வநாய் உண்டாகும் என 
ெிள்ளைப்ெிணி மருத்துேதில் குறிப்ெிடுகிறது 
  உணேினால் மட்டுமின்றி பசயலின்  வேறுொட்டாலும் மாந்த  வநாய்    
குழந்ளதளயத் தாக்கும். ேறுளம, ெசி, துயரம்,மனக்கேளல, ெயம், வகாெம், இச்ளச 
வொன்ற உணர்வுகைால் குழந்ளதயானது தாக்குறும் வொது உணவு  பசரிக்கும்  
தன்ளமயில்  மாறுொடு   நிகழ்ந்து மாந்தம் உண்டாகிறது என ெிள்ளைப்ெிணி 
மருத்துேம்    நூல்  கூறுகிறது 
   வமாதிொல், பநய், கதலிெழம், இைநீர், வதாங்காய், புைித்த வமார், மாமிசம், 
கனிகள், உளுந்து, பமாச்ளச, புைியம்பகாட்ளட, உளுளே, பகாண்ளடமீன், ொகல், 
சுளர, முதலான ோயுப்ெண்டங்களை ொல் பகாடுக்கும் மாதர்கள் மிகுதியாக வநாய் 
உண்டாகும் என ஆேி அைிக்கும் அமுத முளற சுருக்கத்தில் குறிப்ெிடப்ெட்டுள்ைது. 
 
வநாய் ேளககள்: 
குழந்ளத மருத்துேத்தில் மாந்தவநாய் 21 ேளககைாகப் ெிரிக்கப்ெட்டுள்ைது 
1. ேைி மாந்தம் 
2. அழல் மாந்தம் 
3. ஐயல் மாந்தம் 
4. ேிடம் மாந்தம் 
5. வொர் மாந்தம் 
6. ோளல மாந்தம் 
7. சுரம் மாந்தம் 
8. நீர் மாந்தம் 
9. பசரியா மாந்தம் 
10. கட்டு மாந்தம் 
11. ொல் மாந்தம் 
12. எரி மாந்தம் 
13. துைா மாந்தம் 
14. தளல மாந்தம் 
15. கணம் மாந்தம் 
16. ேலிப்பு மாந்தம் 
17. சுழி மாந்தம் 
18. முக்கு மாந்தம் 
19. சந்தி மாந்தம் 
20. ஊதல் மாந்தம் 
21. ேகீ்கம் மாந்தம் 
 











10.கருப்ெம் மாந்தம் எனவும்,  









































மதளல  நூலில் மாந்தம் 13 ேளககைாகப் ெிரிக்கப்ெட்டுள்ைது. 
(கும்ெ முனி ொலோகடம்) 
“வதான்றிய ோத ெித்தம் பசால்லிய சிபலற்ெ மாந்தம் 
ஊன்றியதடுக்கு மாந்தம்ேிச மாந்தம் வொர்மாந்தம் தான் 
கன்றியொல் மாந்தம் ேன்கெ மாந்தம் பொது மாந்தம் ெின்  















ெிள்ளைப்ெினி  மருத்துேம் ொகம் 2 ல் மாந்தத்தின் ேளககள் -53 
43 ேளக மாந்தங்கள் குறிகுணேிைக்கங்களுடன் காணப்ெடுகின்றன . 
மீதமுள்ை 10 மாந்தங்கள் பெயரைேில் மட்டும் ேளகப்ெடுத்தப்ெட்டுள்ைது 
குழந்ளத மருத்துேத்தில் மாந்தத்தின் பொது குறிகுணங்கள்: 
 குழந்ளதயின் உடம்புவசார்ந்து இருத்தல் 
 உடம்பு வநாதல் 
 மிகுதியான ேியர்ளே உண்டாதல் 
 சுறுசுறுப்ொக இல்லாமல் கண்ேிழி சிேந்திருத்தல் 
 கண்கள்குழி ேிழுந்து காணல் 
 முகம் பேளுத்து ஒரு ேளக மங்கிய ஒைி காணல் 
 குரல் தைர்ந்து ோய் உலர்ந்து காணல் 
 அடிக்கடி ோந்தி ஏற்ெடல் 
 ெசி இன்ளம காணல் 
 சீதமும் மலமுமாகவும், பகட்டுவொனொல் வொலவும்,தண்ணரீ் வொலவும் 
நிறமாக வெதியாதல் 
 ளக கால்கள் சூடு இல்லாமல் குைிர்ந்து காணல் 
 ளகயில் தங்காமல் அழதல்   




 நீர்கண மாந்தம் குறிகுணம் குழந்ளத மருத்துேம்   {ொலோகடம் ெக்கம்-176} 
இருமு மூக்கில்  நீர் ேடியும் 
        இளடயில் இளடயில் சுரங்காயும் 
பொருமி ேயிறு இளரச்சலுண்டாம் 
        வொதப் ெலேித மாய்கழியும் 
பசாருகுங் கண்ணும் உடம்புமுகம் 
       வசார்ந்து தளலயும் புரட்டலுண்டாம் 
மருேி மயக்கம் உண்டாகும் 
       ேருகு நீர்க்கண மாந்தமுவம 
குறிகுணங்கள் 
 இருமல் 
 மூக்கில்  நீர் ேடிதல் 
 சுரம் 
 கழிச்சல 
 உடல், முகம் வசார்ேளடதல் 
சித்த மருத்துே  வநாய்கணிப்பு:[Diagnosis] 
 ெிணியறிமுளறளம 
 உயிர் தாதுக்கள் [முக்குற்றம்] 
 உடல் தாதுக்கள் [ஏழு உடற்கட்டுகள்] 
 ெருே காலங்கள் 
 ஐேளக  நிலங்கள் 
 எண்ேளகத் வதார்வு 
  நீர்க்குறி 
  பநய்குறி 
  நாடி 




1) பொறியால் அறிதல் 
2) புலனால்   அறிதல் 
3) ேினாவுதல் 
 நீர்கண மாந்தத்தில்    வநாயாைிக்கு காணும் குறிகுணங்கள்: 
I. பொறியால் அறிதல் 
       மூக்கு- மூக்கு  நீர் ொய்தல் 
       நா  - இயல்பு 
       கண்- சில வேளை கண் சிேத்தல் 
       காது-இயல்பு 
       வதால்-இயல்பு 
II. புலனால் அறிதல் 
ஊறு -  இயல்பு 
ஒளச-  இயல்பு 
      ஒைி-   இயல்பு 
      சுளே- இனிப்புச்சுளே பதரிதல் 
      நாற்றம்- மூக்கில் சைி சவ்வு தடிப்புறுதல் 
III. ேினாவுதல்: 
மருத்துேர்  வநாயாைியிடம் ேினாவுதல் மூலம்  வநாளயக் கணிக்க 
முடியும்  வநாயாைியால் வெச முடியாத வநரத்தில் அேன் சுற்றத்தாரிடம் 
ேினாவுதல் மூலம் வநாளயக் கணிக்க முடியும். 
உயிர் தாதுக்கள்: 
1) ோதம் 
        நீர்கண மாந்தத்தில் ோதத்தின்  நிளல 
a) ெிராணன் :இயல்பு 
b) அொனன்:ொதிப்பு  (சிலேளை கழிச்சல் காணல்) 
c) ேியானன்:ொதிப்பு (உடல் குன்றுதல்) 
d) உதானன்:ொதிப்பு  (இருமல் காணுதல்) 
e) ொதிப்பு (ெசியின்ளம காணல்) 
f) நாகன்: இயல்பு 
g) கூர்மன்: இயல்பு 




நீர்கண மாந்தத்தில் ெித்தத்தின்  நிளல: 
a) அனற்ெித்தம்: ொதிப்பு (ெசியின்ளம காணல்) 
b)  இரசக ெித்தம்: ொதிப்பு (முகம் போளுத்துக் காணல்) 
c) சாதகெித்தம்: ொதிப்பு (உடல் வசார்வு காணல்) 
d) ெிராசகம்: இயல்பு 
e) ஆவலாசகம்: இயல்பு 
3) கெம் 
நீீ்ர்கண மாந்தத்தில் கெத்தின் நிளல: 
a) அேலம்ெகம்: பாைிப்பு (இருமல்) 
b) கிலவதகம்:ொதிப்பு (பசரியாளம) 
c) வொதகம்:இயல்பு 
d) தற்ெகம்:சிலவேளை கண் சிேத்தல் 
e) சந்தீகம்:இயல்பு 
உடற்கட்டுகள்: 
நீர்கண மாந்தத்தில் உடற்கட்டுகைின் நிளல: 
1. சாரம்:ொதிப்பு (உடற்வசார்வு காணல்) 
2. பசந்நீர்:ொதிப்பு (முகம் பேளுத்துக்காணல்) 
3. ஊன்: இயல்பு 





பநய்தல் மற்றும் குறிஞ்சி நிலப்ெகுதிகைில் நீர்கண மாந்த வநாய் 
தாக்கம் அதிகமாக காணப்ெடுகிறது. 
முக்குற்றங்களும்  ெருேகாலங்களும்: 
கார்காலம் மற்றும்கூதிர்காலம் நீர்கண மாந்த வநாய் தாக்கம் 
அதிகமாக காணப்ெடுகிறது. கபக்குற்றம் அைிகரித்து  ைனக்கு 
துதையாக வாை ,பித்ைக்குற்றத்தை அைிகரித்து இந்ந ாய் 
௨ண்டாகிறது 
எண்ேளக வதர்வு: 
"நாடிப் ெரிசம் நாநிறம் பமாழிேிழி 
மலம் மூத்திரமிளே மருத்துேராயுதம்" 
            நீர்கண மாந்த்தில் 8 ேளகத் வதர்வு 
1. நா-இயல்பு 
2. நிறம்-முகம் பே ளுத்துக்காணல் 
3. பமாழி-குரல் ஒலி தாழ்தல் 
4. ேிழி -சிலவேளை கண் சிேத்தல் 
5. மலம்- சிலவேளை கழிச்சல் காணல் 
6. மூத்திரம்-இயல்பு 
7. ெரிசம்-மித பேப்ெம் 
8. நாடி -ோதெித்தம்,ோதகெம்,ெித்தகெம் 
நீர்க்குறி: 
"அருந்துமாறி ரதமும் அேிவராதமாய் 
அஃகல் அலர்தல் அகாலவூன் தேித்தழற் 
குற்றைேருந்தி உறங்கி ளேகளற  
ஆடிக் கலசத் தாேிவய காதுபெய் 
பதாரு முசகூாீ்த்தக் கலளக்குட்ெடு நீரின் 
நிறக்குறி பநய்க்குறி நிருமித்தல் கடவன" 
          வநாய் நாடல் வநாய் முதல் நாடல் ெகுதி-1 
ேிைக்கம்: 
நீர்க்குறி ொர்க்கும் முதல் நாள் இரவு உணவுஉண்டு உறங்க  
வேண்டும்.ெின் ேிடியற்காளல ெடிகொத்திரத்தில் நீரினளப்ெிடித்து 
அதன் நீர்க்குறி மற்றும் நிறக்குறியிளன கண்டறிதல் வேண்டும்.    
'ேந்த நீர் கரிபயளட மணம் நுளரஏஞ்சபலன்                                                                                                 




            3-நுளர 
4-எளட  
5-எஞ்சல் .இேற்ளற காண வேண்டும். 
பநய்க்குறி: 
"நிறக்குறிக் குளரத்த நிருமாண நீரிற் 
சிறக்க பேண்பணய்வயார் சிறுதுைி நடுேிடுத் 
பதன்றுறத் திறந்பதாலி வயாகா தளமந்ததி 
னின்ற திேளல வொம் பநறிேிழியறியும் 
             சிறுநீரில் நல்பலண்பணய் ேிட்டு ொர்ப்ெது” 
வநாயாைியின் சிறுநீளர வசாதளன ேட்டிலில் ஊற்றி   சூரிய ஔி மிகுந்த 
இடத்தில் நீரின் அளலயில்லாத வொது   நல்பலண்பணய்த்துைி ேிட்டு ொர்ப்ெது 
            "அரபேன நீண்டினஃவத ோதம் 
ஆழி வொற் ெரேின் ெித்தம் 
முத்பதாத்து நிற்கின் கெம்" 
ோத நீர் -ொம்பு வொல் ெரவும் 
ெித்த நீர்-வமாதிரம் வொல் ெரவும் 
கெ நீர்-முத்து வொல் ெரவும் 
 
 


















































       Respiratory system is one of the important system in our body , plays main role in 
respiration. Its divided into upper and lower airways. The upper respiratory tract includes 
nose, para nasal sinusitis, pharynx, larynx. Lower respiratory tract includes trachea, bronchi, 
bronchioles and alveoli. 
 
 
UPPER RESPIRATORY TRACT 
     Upper Respiratory Tract refers to the parts of respiratory system lying above the sternal 
angle, above the glottis. It includes the nose, the naso pharynx and the oropharynx. It plays 
main role in fighting with the infection which affects the human being through oral and 
mucosal route. 
 
 ANATOMY & PHYSIOLOGY OF UPPER RESPIRATORY TRACT 
NOSE 
 The nose is the visible part of the respiratory system.  
 Protruding prominently from the face, the nose serves as a vent for air exchange and also 
as the organ of smell.  
 The structures of the nose are divided into two main parts, the External nose and the 
internal nasal cavity.  
 The external nose has a skeletal frame work that is a) partly bony and b) partly 
cartilaginous. 
  The bones are the nasal bones which form the bridge of the nose and the frontal process 
of the maxillae. 
 The cartilages are the superior and inferior nasal cartilages, the septal cartilage and  
Some small cartilages. 
 The nasal cavity extends from the external nares to the posterior nasal apertures.   
It is sub divided into right and left halves by a midline nasal septum. 
      Each half has a: 
 Floor-separates it from oral cavity, formed by the hard palate 
 Roof-narrow & formed by the 
1. Body of sphenoid 
2. Cribriform plate of ethmoid bone 
3. Frontal bone 
4. Nasal bone &cartilage 
  Lateral wall 
           Shows three horizontal bony projections, covered by    mucous   
membrane, the superior, middle & inferior conchae. 
 Medial wall (septum) 
                      Osteocartilagenous partition, covered by the mucoperiosteum 
                      Formed by-superiorly- the vertical plate of ethmoid bone 
                                        Posteriorly-the vomer bone 
                                        Anteriorly-the septal cartilage 
  Arterial supply 
1. Ant ethmoidal artery 
2. Post ethmoidal artery 
3. Sphenopalatine artery 
4. Greater palatine artery 
5. Superior labial artery 
Venous supply 
1. Trigeminal nerve 
2. Ant superior-ophthalmic nerve 
3. Ant inferior-maxillary nerve 
4. Post superior-maxillary nerve 
 
PHARYNX:  
 The pharynx is a wide muscular tube, situated behind the nose, the mouth and the larynx. 
 Length: About 12 cm 
 Width: Upper part is widest and collapsible(3.5cm) 
            Middle part is narrow 
            Lower end is the narrowest of the gastro intestinal tract        
  Clinically it is a part of the upper respiratory tract where the infections are common. 
 It is divided into 3 parts. 
1. Nasopharynx 
           It is the upper part situated behind the nose and above the lower border of soft 
palate and it transmit only air. 
2. Oropharynx 
              It is the middle part of the pharynx situated behind the oral cavity and it transmits      
both air and food. 
3. Laryngopharynx 
           It is the lower part.it extends from the upper border of epiglottis to the lower border 
of cricoid cartilage and it transmit only food 
 Boundaries 
Superiorly 
Base of the skull 
Posterior part of the body of the sphenoid 
Basilar part of the occipital bone 
In front of the pharyngeal tubercle 
Inferiorly 
Continuous with oesophagus 
Lower border of cricoid cartilage 
Posteriorly 
 Prevertebral fossa 
Anteriorly 
It communicates with the nasal cavity, oral cavity, and larynx. The anterior wall o f 
the Pharynx is incomplete. 
Laterally 
 It communicates with middle ear cavity 
 Mandible 
 Tongue 
 Pterigoid plate 
 Hyoid bone 
 Thyroid 
 Muscle of the pharynx 
      The muscular basis of the wall of the pharynx is formed by 3 pairs of constrictors 
namely Superior, middle and inferior constrictors. 
 Nerve supply 
 Pharyngeal branch of the vagus 
 Pharyngeal branches of the glosso pharyngeal nerve 
 Pharyngeal branches of superior cervical sympathetic ganglion 
 Cranial accessory nerve 
 Maxillary nerve 
 Blood supply 
Arteries 
Ascending pharyngeal branch of the external carotid artery. 
Ascending palatine and tonsilar branches of the facial artery. 
Dorsal lingual branches of the lingual artery. 
The greater palatine pharyngeal and pterigoid branches of maxillary artery. 
Veins 
 Internal jugular vein 
 Facial vein 
Lymphatics 
Retropharyngeal, deep cervical lymph nodes. 
Physiology 
 The  functions of nose are 
1. Provides an Airway for Respiration 
2. Moistens and Warms Entering Air 
3.  Filters Inspired Air and Cleanses It of Foreign Matter 
4. Serves as a Resonating Chamber for Speech 
5. Houses the olfactory (smell) receptors 
The  functions of pharynx are 
1. Respiration 
2. Swallowing 
3. Language formation 















                                




                                  ACUTE NASO PHARYNGITIS  
                                        (COMMON COLD) 
 
         Acute naso pharyngitis is commonly known as cold.  It is an inflammation of the mucous 
membranes of the upper pharynx, the naso pharynx or the naso pharyngeal duct which extends 
between the oral and nasal palate. It is also referred as upper respiratory infection or rhinitis. It is 




         It has both Infective and non-infective cause. Non infective cause like allergic to food, Low 
socio economic status , Dust allergy ,environmental changes like pollution ,climate change  and 
family history can causes naso pharyngitis.  A virus or bacteria   causes infective naso   
pharyngitis. Although viruses causes most acute naso pharyngitis episodes, group A streptococcus 
causes 37% of infection in children   older than 5 years ,other bacterial cause of infection are  
group C streptococcus (5%),anaerobic species (1%) .Between viruses Rhino virus, Corna virus 
and Adeno virus account for the 30% of total case. It can spread through tiny air droplets that are 
expelled when a person infected   sneezes. 
 
EPIDEMOLOGY  
                      
   Naso pharyngitis exists latently in a large number of people and pathological examination 
revealed the presence of inflammation in all subjects aged from 12hours after birth to 80 years. 
Streptococcal pharyngitis has a peak incidence in early school years.  Illness occurs most often in 
winter & spring. The infection is transmitted   via respiratory secretions and the incubation period 
is 2-5 days. Communicability of infection is highest during acute phase and in untreated people 
gradually diminishes over a period of weeks. 
 
PATHOLOGY 
              
         The symptoms of the common cold are believed to be primarily related to the immune 
response to the virus. The mechanism of this immune response is virus specific. For example, the 
rhinovirus is typically acquired by direct contact; it binds to human ICAM-1 receptors through 
unknown mechanisms to trigger the release of inflammatory mediators. These inflammatory 
mediators then produce the symptoms. It does not generally cause damage to the nasal epithelium.  
The respiratory syncytial virus (RSV), on the other hand, is contracted by direct contact and 
airborne droplets. It then replicates in the nose and throat before frequently spreading to the lower 
respiratory tract. Respiratory syncytial virus does cause epithelium damage. Human Para influenza 
virus typically results in inflammation of the nose, throat, and bronchi. In young children when it 
affects the trachea it may produce the symptoms of croup due to the small size of their airways. 
       
CLINICAL MANIFESTATIONS: 
 
IN YOUNGER CHILDREN 
 In General, children 3 months-3 years have fever in the early course of infection. 
 Few hours before onset of fever, sneezing, irritability and restlessness present. 
 Nasal discharge begins within few hours quickly leading to nasal obstruction. 
 A few infant may vomit and some have diarrhea 
 
IN OLDER CHILDREN 
 The initial symptoms are dryness and irritation in the nose , these symptoms follow with in 
few hours 
 Watery nasal discharge 
 Sneezing 
 Coughing 
 Muscular aches 
 Head aches 
 Malaise 
 Anorexia 
 Low grade fever may be present 
Common Cold Complications 
• Sinus infection (acute sinusitis) Acute sinusitis is characterised by inflammation and 
swelling of the mucous membranes that line your sinus cavities 
• Asthma attack 
• Acute bronchitis (chest cold)  
• Sore throat and tonsillitis.  
























                                  Trial drug 
PREPARATION AND PROPERTIES OF TRIAL DRUG 
                              OMA KUDINEER 
Ref: Balavagadam, page 67 
Ingredients: 
1. Pepper-35gm {1palam} 
2. Long pepper-35gm{1 palam} 
3. Garlic-35gm{1palam} 
4. Omam-35gm {1palam} 
Method of preparation:  
       All the drugs were taken equal ratio purified and grinded to the powder form. Required 
quantity is taken from the grinded powder and mixed with1300mlof pure water and this 
mixture is boiled until the concentrated170ml  decotation of the ingredient is obtained 
Dose: 4-8ml depending upon age (twice a day) 
Duration: 7 days  
  




     
    Botanical Name:  Piper longum 
English Name: Long pepper 
Family:piperacea 




பொது குணம் : 
           “ ஈளை யிருமல் லிளரப்பு ெசப்ெிணிகள் 
            மாை போழியாமல் ோட்டுவம -யாளுமுளற 
            ொங்கா யறிந்து பசய்ோீீ் ெண்டிதத்தளப் ெண்டிதவர 
            வேங்ளகோய் ொன்களன பமய்." 
                                                                              -     நைரன் வவண்பா 
Chemical constituents: piperine ,piperlongumine 
Actions: stimulant, carminative 
Pharmacological activity: anti-bacterial 













வபாது குைம் : 
தீயாகி பயங்கும்  திரியுமளத யாேத்து 
வமாயாம பலப்ெடியு முண்டாக்காற் -ொயாது 
வொந்திமிர்ோ தங்கிரந்தி புண்ணரீும் மண்ணேக்கும் 
காந்திபமய்ோ தச்சலுப்ளெக் காய். 



















சீதசுரங் காசஞ் பசாயாமந்தம் பொருமல் 
வெதியிளரச் சல்கடுப்பு வெராம்  -ஓதிருவமல் 
ெல்பலாடுெல் மூலம் ெகமிளேவநா பயன்பசயுவமா 
பசால்பலாடுவொம் ஓமபமனச் பசால். 

















      சன்னிபயாடு ோதந் தளலவநாவு தாள்ேலி 
      மன்னிேரு நீாீ்க்வகாளே ேன்சீதம்-அன்னம்! 
      உள்ளுள்ைி கண்ொய் உளைமூல வராகமும் வொம் 
      பேள்ளுள்ைிதன்னால்பேருண்டு.                                                                                                                              
.            -அகத்ைியர் குைவாகடம். 
Chemical constituents:Alliin,ajoene 
Actions: Expectorant, stomachic, tonic, carminative 
Pharmacological activities:expectorant,stimulant,carminative 
























         After finishing the toxicity studies 40 paediatric cases were selected on the basis 
of inclusion criteria from the OPD of Kuzhanthai Maruthuvam Department, Arignar 
Anna Govt Hospital, Chennai. They were treated with the trial drug Oma kudineer 




 A clinical trial on Neer kana Mantham was carried out in the post graduate 
department of kuzhanthai maruthuvam in Govt.Siddha.Medical.College attached to 
Aringar Anna Hospital of Indian Medicine, Chennai-106 during the period of 2015-
2017  
The study was approved by Institutional Ethics Committee [IEC] and the 
approval number is IEC No: GSMC-CH-ME-4/020/2015 
Sample size 
The study is conducted in 40 selected patients of both genders between age groups of 
2 to 12 years 
Inclusion Criteria: 
 Age 2-12 yrs. 





 Patient having any three symptoms are included in my trial 
Exclusion Criteria 
 Bronchitis. 
 Bronchial Asthma. 
 Severe Diarrhoea. 
Withdrawal Criteria 
 Exacerbation of the symptoms. 
 Occurrence of any adverse effects. 
 Patients turned to unwilling during follow up. 
Assessments and Investigations 





 Loss of appetite 
 
         Siddha Assessment 
 Naa 
 Niram 





 Moothiram-Neer Kuri ,Nei Kuri 
Routine Tests and Investigations 
Blood: TC, DC, ESR, Hb. 
Urine: Albumin, Sugar, Deposits. 
Methodology of Treatment 
Study Enrolment: 
 Patient reporting at the OPD associated with clinical features of Running nose, 
cough, fever, malaise, fatigue are chosen for enrolment based on the inclusion criteria. 
The patients who are enrolled are informed about the study trial drug, possible 
outcomes and the objectives of the study in the language ant terms understandable to 
them and then informed consent/assent would be obtained from the patient/patients 
parent using consent/Assent form. 
Conduct of the Study: 
 The trial drug will be given in the OPD department of Kuzhanthai 
Maruthuvam, GSMC, and Chennai. The patients will be asked to have a regular 
follow up in the OPD department once in 3days. In each and every visit the clinical 
assessment will be recorded in the prescribed proforma. The laboratory investigation 
will be done before and after treatment and recorded in the prescribed format. 
Data collection forms: 
 Required information will be collected from each patient by using following 
forms. 
Form I    : Screening and selection proforma. 
Form II   : History taking proforma. 
Form III   : Clinical assessment proforma. 
Form IV   : Clinical assessment during and after trial. 
Form V    : Laboratory Investigation proforma. 
Form VI   : Informed consent/Assent form. 
Form VII: Withdrawal form. 
Form VIII: Patient information sheet. 
Data Analysis: 
 After enrolling the patients in the study a separate file for each patient will be 
maintained and all forms will be kept in the file. Whenever the patient visits OPD 
during the study period necessary entries will be made in the assessment forms. The 
data entries and adverse events if any will be monitored by the Head of the 
Department. 
Outcome of Treatment: 
Primary Outcome: 
 Primary outcome is mainly assessed by comparing the reduction in clinical 
symptoms and recurrence before and after treatment. 
Secondary Outcome: 
 Secondary outcome is assessed by comparing the safety parameters before and 
after treatment. 
Adverse effect and Serious effect Management: 
 If the trial patient develops any adverse reactions the patient will be referred to 
the Pharmacovigilance department of SCRI and documented. For any adverse effect 
the investigator will give the proper management in the OPD. 
Ethical issues:                                                                                                                                  
1. Informed consent/Assent will be obtained from the patient/patient’s parent 
or guardian after explaining about the clinical trial in an understandable 
language 
2. After the consent/Assent of the patient or patient’s parent (through    
    consent/Assent) if   they fit in the criteria they will be enrolled in the study. 
3. Treatment will be provided free of cost. 
4. Concomitant medicines will be used if there is any need.  
5. The patients who are excluded (as per the exclusion criteria) will be refer   
    to OPD 
 
6. In conditions of treatment failure, adverse reaction patients will be given   




























RESULTS AND  
OBSERVATIONS 
 
              







 RESULTS AND OBSERVATIONS 
 
A total number of 40 child patients with signs and symptoms of Neer Kana Mantham 
attending PG-IV, Kuzhanthai Maruthuvam Out Patient Department in Govt. Siddha Medical 
College attached to Aringnar Anna Hospital were observed in the present study. The 
observations were made and tabulated with regards to the following features: 
1. Age Distribution 
2. Gender Distribution 
3. Family History 
4. Diet history 
5. Socio-Economic status 
6. Uyirthathukkal 
7. Udarthathukkal 




12. Clinical Features 
13. Prognosis 













 1. AGE DISTRIBUTION 
 
SNO Age No of Cases(out 
of 40) 
Percentage 
1 2-3 years 4 10% 
2 4-6 Years 14 35% 
3 7-10 Years 15 37.5% 





The above table indicates that children coming under 2-3 yrs. of age group were 10%, 
4-6yrs were 35%, 7-10 yrs were 37.5% and 11-12 yrs were 17.5% respectively.  












2. GENDER DISTRIBUTION 
 












Among 40 cases for this study, 21 children ie 52.5% were male and 19 children ie 













3. FAMILY HISTORY 
 
SNO Family History No of Cases(out of 
40) 
Percentage 
1 Positive 8 20 % 























 4. DIET HISTORY 
 
 
Dietary  habits No of cases out of 40 Percentage 
vegetarian 5 12.5% 




















 5. SOCIO ECONOMC STATUS 
 
S.No Status No. of  cases Percentage 
1 Rich 5 12.5% 
2 Middle 16 40% 
























S.No. Vatham No. of cases out of 40 Percentage 
1. 
 
Praanan - - 
2 Abaanan - - 
3 Vyanan 5 12.5% 
4 Udhanan 40 100% 
5 Samaanan 15 37.5% 
6 Naagan - - 
7 Koorman - - 
8 Kirukaran 40 100% 
9 Devadhathan - - 





      In vatham, vyanan was affected in 5 cases ie 12.5%, samaanan was affected in 15 
























S.NO Pitham No of cases Percentage 
1 Anal Pitham 35 87.5% 
2 Ranjaga Pitham 8 20% 
3 Saathaga Pitham. 10 25% 
4 Prasaga Pitham - - 
5 Aalosaga Pitham - - 
 
 
Inference    :  
In Pitham, Anal pitham was affected in 35 cases ie 87.5%, Ranjaka pitham was affected in 8 





































                      
 
Inference:  














0 0 0 
kabam
s.no Kabam Types No of cases out of 40 Percentage 
1 Avalambakam - - 
2 Kilethakam 10 25% 
3 Pothakam - - 
4 Tharapakam - - 
5 Santhikam - - 
 7. Udarthathukkal: 
S.No Udarthathukkal No Of Cases Out Of 40 Percentage 
1 Saaram 40 100% 
2 Senneer 8 20% 
3 Oon - - 
4 Kozhuppu - - 
5 Enbu - - 
6 Moolai - - 




In udharthathukkal, saaram was affected in 40 cases ie 100% and senner was affected in 8 
cases ie 20%. 
 
 




































 In envagai thervugal, Naa was affected in 25% cases, Niram and vizhi was affected in 20% 
cases and sparisam was affected in 27.5% cases. In case of Naadi was seen as vatha pitham 



















s.no Siddha parameters No Of Cases Affected Percentage 
1 Naa 10 25% 
2 Niram 8 20% 
3 Mozhi - - 
4 Vizhi 8 20% 
5 Sparism 11 27.5% 
6 Malam - - 

















All the 40 cases were reported from surroundings of Chennai which is belongs to Neithal 

















S.No Nilam No Of Cases Out Of 40 Percentage 
1 Kurinji 0 - 
2 Mullai 0 - 
3 Marudham 0 - 
4 Neithal 40 100% 





The table shows that more prevalence of the disease is under Munpanikalam-50% ,30% of 
















S.No Paruvakaalam No Of Cases Out Of 40 Percentage 
1 Kaarkaalam  
 
0 0 
2 Koothirkaalam 12 30% 
3 Munpanikaalam 20 50% 
4 Pinpanikaalam 8 20% 
5 Elavenilkaalam 0 0 
6 Muduvenilkaalam 0 0 
11. Neikkuri 
S.No Neikkuri No Of Cases Out Of 40 Percentage 
1 Vathaneer 26 65% 
2 Pithaneer 11 27.5% 





Among 40 cases, vathaneer was observed in 26 cases ie 65%, pithaneer was observed in 11 



























The above table reveals that, among 40 cases, had  cough 100% before treatment was 
reduced to 5% and 100% of cases had Running nose  before treatment was reduced to 




























BEFORE TREATMENT AFTER TREATMENT 
  NO of cases (out of 
40) 
Percentage NO of cases 
(out of 40) 
Percentage 
1 Cough 40 100 2 5 
2 Running Nose 40 100 3 7.5 
3 Fever 11 27.5 1 2.5 
4 Malaise 4 10 1 2.5 
5 Diarrhea 0 0 0 0 
13. RESULTS OF NEER KANA MAANTHAM 
 
SNO Prognosis No of Cases 
(Out of 40) 
Percentage (%) 
1 Good 32 80 
2 Moderate 6 15 








Among 40 patients, 32((80%) cases showed good improvement, 6(15 %) cases 









             















SNO OP.NO Name Age/Sex Days treated Remarks 
1 4438 Shifa 2yrs/Fc 9 Good 
2 6157 Kaviyasree 21/2 yrs/Fc 7 Good 
3 4596 Nasser 3yrs/Mc 8  Good 
4 9883 Yuvan Shankar 31/2 /Mc 11 Good 
5 6644 Veeras 4yrs/Mc 6 Moderate 
6 9921 Prajan 4 yrs/Mc 7 Moderate 
7 9720 Sanjana 4yrs/Fc 11 Good 
8 7745 Sagithya 4yrs/Fc 9 Good 
9 7414 Devmadhavan 5yrs/Mc 10 Good 
10 238 Ashwin karthick 5yrs/Mc 8 Good 
11 562 Ganesh kumar 5yrs/Mc 10 Moderate 
12 5981 Kaanishka 5yrs/Fc 9 Good   
13 7617 Priyadarshini 6yrs/Fc 7 Good 
14 5114 Harifa 6yrs/Fc 7 Good 
15 8102 Aswin 6yrs/Mc 8 Good 
16 5694 Srinivedha 6yrs/Fc 7 Good 
17 7540 Sharon 6yrs/Mc 6 Good 
18 1752 Akash 6yrs/Mc 9 Good 
19 2172  Nitish 7yrs/Mc 8 Good  
20 5795 Sridhar 7yrs/Mc 7 Moderate 
21 3754 Keerthana 7yrs/Fc 6 Good 
22 3847 Shakilabanu 7yrs/Fc 7 Good 
23 3869 Banbalan 8yrs/Mc 5 Moderate 
24 6650 Nirekha 81/2yrs/Fc 6 Good 
25 1320 Bhavadarini 9yrs/Fc 8 Good 
26 2702 Rithika 9yrs/Fc 7 Good 
27 4524 Swetha 9yrs/Fc 10 Moderate 
28 5636 Karthick 91/2 yrs/Mc 8 Good 
29 9564 Udhya saravanan 9yrs/Mc 10 Good 
31 3958 Gunapriya 10yrs/Fc 5 Good 
32 6358 Surendar 10yrs/Mc 7 Good 
33 3256 Sanjana 10yrs/Fc 7 Good 
34 5709 Abi 11yrs/Fc 8 Good 
35 9963 Rithika 11yrs/Fc 10 Mild 
36 398 Akshaya 11yrs/Fc 8 Good 
37 6769 Charles 12yrs/Mc 7 Good 
38 2261 Kalaiselvan 12yrs/Mc 8 Good 
39 5690 Sarvendiran 12yrs/Mc 7 Good 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































          Neer kana maantham is a most common, repeated disease of the children 
mainly affecting the upper respiratory tract with or without inflammation The disease 
is characterized by cough,  Running nose, fever, Malaise, Diarrhoea  and lack of 
appetite. 
         In this study, 40 cases were selected according to the proforma with undergone 
investigation and treated with the trial drug OMA KUDINEER for 7 days with after 
treatment investigation in the OPD of PG-Dept of Kuzhanthai Maruthuvam, Govt. 
Siddha Medical College attached to Arignar Anna Hospital of Indian 
Medicine,Chennai-106. The data were collected and prognosis of the disease with the 
trial drug was clearly observed. 
           This study evaluate the effect of OMA KUDINEER” on NEER KANA 
MAANTHAM  (Acute nasopharyngitis). 
The observations are described here 
1. Age Distribution 
According to children’s age under 2-3years of age group were 10%, 4-6 years were 
35%, 7-10 years were 37.5%, 11-12 years were 17.5% respectively. Hence this study 
reveals that Neer kana mantham  was prevailed more in 7-10 years children. 
2. Gender Distribution 
Among the 40 cases for this present study, 21 (52.5%) children were male and 
19(47.5%) children were female. According to modern theory there is no apparent 
gender prediction 
3. Family History 
According to family history, 8 (20%) cases were reported positive family history,and 
32  (80%) cases have negative family history. Hence family history may impact on 
Neer kana maantham. 
4. Socio Economic status 
Regarding socio-economic status, 19 (47.5%) cases were belong to poor status,16 
(40%) cases were belong to middle class and 5 (12.5%) cases belong to high class. 
The highest incidence was observed in poor class children due to poor hygiene, 
malnutrition, exposure to polluted environment lower their immune response, so the 
poor children are more prone to the disease. 
5. Uyir Thathukkal 
Disturbance of Vatham 
In 40 cases, among 10 types of Vatham, Vyanan,Udhanan, Samanan and Kirukaran 
are affected. Udhanan and Kirukaran are affected in 100% of cases, Vyanan is 
affected in 5% cases and Samanan is affected in 15%cases. 
Disturbance of Pitham 
In 40 cases, among 5 types of pitham,Anal pitham is affected in 87.5% cases, ranjaga 
pitham is affected in 20% cases and saathaga pitham is affected in 25% cases. 
Disturbance of Kabam 
In 40 cases, among 5 types of kabam,Avalambakam is affected in 100% cases and 
Klethakam is affected in 25% cases. 
6.Udarthathukkal 
In Udarthathukkal, Saaram was affected in all 100% cases and Senneer was affected 
in 20% cases . 
7.Ennvagai Thervugal 
Among 40 cases, Naa is affected in 25% cases,Niram is affected in 20%, Vizhi is 
affected in 20% cases ,sparism is affected in 27.5% cases and the Naadi felt among 40 
cases were vathapitham in 40% cases, vathakabam in 25% cases and pithakabam in 
35% cases. 
8. Neikuri 
Among 40 cases, Vatha neer was observed in 60% cases, Pitha neer was observed in 
27.5% cases, Kaba neer was observed in 7.5% cases. 
9. According to Paruvakaalam 
Regarding Paruvakaalam among 40 cases, 5% cases were reported in Koothir kaalam 
and Elavenil Kaalam, 15% cases were reported in Munpani kaalam, 55% cases were 
reported in Pinpani kaalam and 20% cases were reported in Muduvenil kaalam 
respectively. 
10. Distribution of Nilam 
All the 40 cases reported were from surroundings of Chennai which belongs to 
Neithal nilam 
11. Clinical Presentation 
Out of 40 patients, before treatment all the 40 patients had 100% of cough, 100% of  
Running nose, 27.5% of  fever and10% of  Malaise. After treatment most of the 
patients were relieved from the symptoms of  cough, fever, running nose  and  
malaise.  Improvement in appetite is increased in most of cases additionally. 
12. Phytochemical analysis 
The Phytochemical analysis of the trial drug shows that the drug contains iron 
,chloride, Alkaloids ,Flavonoids, Carbohydrates, tri terpenoids,  phenol, glycosides, 
Tannins and proteins . 
13. Toxicity study of the drug 
Acute toxicity study of the trial drug was carried out in Wister Albino rats reveals that 
the drug has no adverse effects, so it is safe for human beings. 
14. Physicochemical analysis 
Moisture content of the drug is 1.1%. 
PH of the drug is 6, 
Ash value-9.98% 
15.Bio Chemical Analysis: 
Biochemical analysis of the drug showed the presence of chloride, iron and zinc. 
16. Pharmacological analysis: 
Pharmacological analysis showed the drug has convincing Anti-inflammatory action 
and showed  no Anti-microbial activities against both gram positive and gram 
negative micro-organism. 
 17. Statistical Analysis 
The preclinical studies of trial medicine statistically analyzed  and showed significant  
result. 
18. Results 
The outcome of this study showed encouraging results. Among the 40 patients good 
improvement observed in 80%, moderate improvement in 15% and mild improvement 
in 5% and no adverse events observed clinically during the course of treatment. 
 
 











                                        SUMMARY 
 
      The disease Neer Kana Mantham was taken for the clinical study with Oma kudineer as 
internal medicine. For the clinical study, 40 patients were selected based on Inclusion and 
Exclusion criteria. The study is conducted after the drug being screened by the Screening 
committee and the trial is also approved by the Institutional Ethical Committee (IEC). 
Animal studies are carried out after obtaining proper permission from the Institutional 
Animal Ethical Committee (IAEC). Hence the study is safely executed on human volunteer 
patients and there was no adverse drug reactions noted during the study period. 40 children 
with Neer kana maantham diagnosed clinically treated in out patient department of Arignar 
Anna Hospital of Indian Medicine,Chennai-106. They were observed for clinical 
improvement, laboratory investigation done and treated with trial drug. 
   I like to summarize this study with the following highlights. 
  al drug Oma kudineer were studied and observed in this 
study. 
  f Neer kana maantham was done on the basis of clinical 
features described in Bala vagadam(siddha pediatric book) 
   comparatively economic. These drugs are 
easily available and the dosage is also convenient. 
  
chemical analysis and pharmacological analysis. 
  f Alkaloids, 
flavonoids, glycosides, carbohydrates, triterpnoids, tannins, phenols& proteins. 
   the trial drug shows the PH-6, and Ash value -
2.44% , So it shows the safe and effectiveness of the drug. 
 l analysis of the drug reveals that it possesses convincing            
Anti-inflammatory property. 
  , 80% cases had shown Good improvement, 15% 
cases had shown Moderate improvement, 5% had shown Mild improvement. 
 made during the clinical study showed that the trial drug was 












                                       CONCLUSION 
      Neer kana Maantham is a common disease in children and mainly caused by 
derangement of kaba kuttram. In this clinical study Oma kudineer was taken as Internal 
drug respectively.The deranged kabam is settled down by the kaarppu suvai in the trial 
medicine there by the medicine acts as Ethirurai maruthuvam to cure the 
disease.Toxicological studies showed no acute toxicity. The  drug has got Anti 
inflammatory activity .The cost of the trial medicines are low .During the clinical study no 
adverse events were observed. 
       The clinical study confirms the efficacy of the trial drugs by reducing the clinical signs 
and symptoms like Cough, cold, running nose ,Fever, and loss of appetite. Clinical study 
results found to be  Good in 80% cases, Moderate in 15% cases, and Mild in 5% cases .The 
Clinical trial conducted in selected patients was satisfactory and encouraging. The trial 
medicine is effective for Neer kana Maantham in children. Through this study, the 
effectiveness of trial drug is confirmed and re-established by the author and concluded that 


















































BIOCHEMICAL ANALYSIS OF OMA KUDINEER 
 
PREPARATION OF EXTRACT: 
2  gm of Oma kudineer sample is taken  in a100 ml beaker and 20 ml of distilled 
water is added. The solution is boiled for 10 minutes, cooled and then filtered. The 
filtrate is called extract.  
S.NO EXPERIMENT OBSERVATION INFERENCE 
1 TEST FOR ACID RADICLES   
A Test for chloride : 
2ml of extract is added with 
dilute Nitric acid till the 
effervescence ceases. Then 2ml 
of silver nitrate solution is 
added. 
Presence of white 
Precipitate 
Present 
B Test for phosphate: 
2 ml of the extract is treated 
with 2 ml of Ammonium 
molybdate solution and 2 ml of 
concentrated nitric acid 
Absence of Yellow 
Precipitate 
Absent 
C Test for carbonate: 
2 ml of the extract is treated 
with 2 ml of Magnesium 
sulphate solution 
Absence of white 
Precipitate 
Absent 
D Test for sulphide: 
1 gm of the substance is treated 
with 2 ml of concentrated 
Hydrochloric acid 
Absence of Rotten egg 
Smelling 
Absent 
E Test for sulphate: 
2ml of the above prepared 
extract is taken in a test tube.to 
this add 2ml of 
4 % Ammonium oxalate 
solution. 







2 TEST FOR 
BASIC RADICALS 
  
A Test for copper: 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric acid 
in a watch glass and introduced 
into the non-luminous part of 
the flame. 
Absence of Bluish 
green colored flame 
Absent 
B Test for iron: 
To the 2 ml of extract 2ml of 
Ammonium thiocyanate 
solution and 2ml of 
concentrated Nitric acid is 
added. 
Presence of Blood red 
colour 
Present 
C Test for zinc: 
To the 2 ml of extract Sodium 
hydroxide solution is added in 
drops in excess 
White precipitate is 
obtained 
Present 
D Test for calcium: 
To the 2 ml of extract 
Ammonium oxalate solution 
solution is added 
Absence of white 
precipitate 
Absent 
E Test for magnesium: 
To the 2 ml of extract Sodium 
hydroxide solution is added in 
drops in excess 
Absence of white 
precipitate 
Absent 
F Test for starch: 
2 ml of extracts treated with 
weak iodine solution 
Absence of white 
precipitate 
Absent 
G Test for reducing sugar : 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 10 drops of 
the extract and again boiled for 
2minutes.The colour changes are 
noted 
Absence of white 
precipitate 
Absent 
H Test for alkaloids : 
2 ml of the extract is treated 
with 2ml of Potassium iodide 
solution. 
Presence of red colour Present 
I Test for ammonium: 
To the 2 ml of extract few ml 
of Nessler’s reagent and excess 
of Sodium hydroxide solution 
are added. 





The Given Sample Oma kudineer  Contains-Acid Radicals-Chloride 











   
  
Physicochemical Evaluation 
Project ID  : NRS/AS/0021/01/2017  
Institute  : Govt Siddha Medical College  
Sample Name  : Oma Kudineer 
Sample ID   : OK  
Percentage Loss on Drying 
10gm of test drug was accurately weighed in evaporating dish .The sample 
was dried at 105
o
C for 5 hours and then weighed. 
Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 100 
Determination of Total Ash 
3 g of test drug was accurately weighed in silica dish and incinerated at the furnace a 
temperature 400 ºC until it turns white in color which indicates absence of carbon. 
Percentage of total ash will be calculated with reference to the weight of air-dried 
drug. 
Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of Acid Insoluble Ash 
The ash obtained by total ash test will be boiled with 25 ml of dilute 
hydrochloric acid for 6mins. Then the insoluble matter is collected in crucible and 
will be washed with hot water and ignited to constant weight. Percentage of acid 
insoluble ash will be calculated with reference to the weight of air-dried ash. 
Acid insoluble Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of Water Soluble Ash 
The ash obtained by total ash test will be boiled with 25 ml of water for 5 
mins. The insoluble matter is collected in crucible and will be washed with hot water, 
and ignite for 15 
minutes at a temperature not exceeding 450ºC. Weight of the insoluble matter will be 
subtracted from the weight of the ash; the difference in weight represents the water 
soluble ash. Calculate the percentage of water-soluble ash with reference to the air-
dried drug. 
Water Soluble Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of Alcohol Soluble Extractive 
About 5 g of test sample will be macerated with 100 ml of Alcohol in a closed 
flask for twenty-four hours, shaking frequently during six hours and allowing to stand 
for eighteen hours. Filter rapidly, taking precautions against loss of solvent, evaporate 
25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, and dry at 105ºC, 
to constant weight and weigh. Calculate the percentage of alcohol-soluble extractive 
with reference to the air-dried drug. 
Alcohol sol extract = Weight of Extract/ Wt of the Sample taken X 100 
Determination of Water Soluble Extractive 
About 5 g of the test sample will be macerated with 100 ml of chloroform 
water in a closed flask for twenty-four hours, shaking frequently during six hours and 
allowing to stand and for eighteen hours. Filter rapidly, taking precautions against loss 
of solvent, evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow 
dish, and dry at 105ºC, to constant weight and weigh. Calculate the percentage of 
water-soluble extractive with reference to the air-dried drug. 
Water soluble extract = Weight of Extract/ Wt of the Sample taken X 100 
Determination of pH 
About 5 g of test sample will be dissolved in 25ml of distilled water and 
filtered the resultant solution is allowed to stand for 30 mins and the subjected to pH 
evaluation  
Final Test report 
S.No Parameter Mean (n=3) SD 
1.  Loss on Drying at 105 °C (%) 7 ± 2.26 
2.  Total Ash (%)  9.98  ± 2.44 
3.  Acid insoluble Ash (%) 3.2 ± 1 
4.  Water Soluble Ash (%) 13.73  ± 0.61 
5.  Alcohol Soluble Extractive (%) 15.66  ± 1.59 
6.  Water soluble Extractive (%) 25.33  ± 2.01 
7. PH  6 
 
 Reference:  
1. India Pharmacopeia I Volume I, Government of India, Ministry of Health and 
Family welfare, Indian Pharmacopeia commission, 2014. 
2. Pharmacopoeial Laboratory for Indian Medicine (PLIM) Guideline for 
standardization and evaluation of indian medicine which include drugs of  
Ayurveda,  Unani and  Siddha systems. Department AYUSH .Ministry of 







































                                                    PHYTOCHEMICAL ANALYSIS 
 
 Sample Preparation 
Oma Kudineer  (OK) was extracted with hydro alcoholic solvent (Methanol: water) 6:4 
and the extract was subjected to the following analysis 
Test for alkaloids: 
Mayer's Test: To the extract, 2ml of mayer's reagent was added, a dull white precipitate 
revealed the presence of alkaloids. 
 
1) Test for coumarins:  
       To 1 ml of extract, 1 ml of 10% sodium hydroxide was added. The presence of coumarins is           
indicated by the formation of yellow color. 
2) Test for saponins:  
       To 1 ml of the extract, 5 ml of water was added and the tube was shaken vigorously. 
Copious lather formation indicates the presence of Saponins. 
3) Test for tannins:  
       To the extract, ferric chloride was added, formation of a dark blue or greenish black color 
showed the presence of tannins. 
4) Test for glycosides- Borntrager’s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water bath, 
filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated and 
10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
5) Test for flavonoids: 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were been added 
followed by addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates 





 6)Test for phenols: 
Lead acetate test: The extract was taken; 3 ml of 10% lead acetate solution was 
added.  A bulky white precipitate indicated the presence of phenolic compounds. 
 
7)Test for cardial glycosides: 
       Keller-Killani Test: Plant extract treated with 2 ml glacial acetic acid containing 
a drop of   FeCl3 .A brown colour ring indicates the presence of positive test. 
 
8)Test for steroids: 
       To the test solution 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube was turns into 
red and sulphuric acid layer showed yellow with green fluorescence. It showed the 
presence of steroids. 
9)Test for Quinones:  
The extracts were treated separately with Alc. KOH solution. Appearance of 
colors ranging from red to blue indicates the presence of Quinones. 
 
10)Test for Cyanins 
A. Aanthocyanin: 
       To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated 
for 5 min at 100ᵒC. Formation of bluish green colour indicates the presence of 
anthocyanin. 
B. Betacyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated 
for 5 min at 100ᵒC.  Formation of yellow colour indicates the presence of 
betacyanin. 
11)Test for Carbohydrates - Benedict’s test 
To 0.5 ml of test drug about 0.5 ml of Benedic’s reagent is added. The mixture 
is heated on a boiling water bath for 2 minutes. A characteristic coloured precipitate 
indicates the presence of sugar. 
 
12)Test for terpenoids: 
Salkowski test: 5ml of extract was mixed in 2ml of chloroform, and concentrated 
sulphuric acid was carefully added to form a layer.  A reddish brown colouration 





Test for Alkaloid 
 
 












Test for Tanins 
 
 





Test for Flavonoids 
 
 












Test for Cardiac Glycosides 
 
 
Test for Steroids 
 
 
Test for Terpenoids 
 




Test for Anthocyanins 
 
 
























+   Indicates positive 




 Brain KR, Turner TD. The Practical Evaluation of 



















TLC AND HPTLC 
ANALYSIS REPORT  
  
 
TLC Analysis Report 
Project ID  : NRS/AS/0021/01/2017  
Institute   : Govt Siddha Medical College  
Sample Name  : Oma Kudineer 
Sample ID   : OK  
TLC Analysis 
Test sample OK was subjected to thin layer chromatography (TLC) as per 
conventional one dimensional ascending method using silica gel 60F254, 7X6 cm 
(Merck) were cut with ordinary household scissors. Plate markings were made with 
soft pencil. Micro pipette were used to spot the sample for TLC applied sample 
volume 10-micro liter by using pipette at distance of 1 cm at 5 tracks. In the twin 
trough chamber with different solvent system Ethyl acetate: Methanol: Water 
(100:13.5:10) After the run plates are dried and was observed using visible light 






Visible         Short UV   Long UV 
 
            
                                         
Reference 
Lukasz Komsta, Monika Waksmundzka-Hajnos, Joseph Sherma . Thin Layer 




High Performance Thin Layer Chromatography Analysis 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to 
achieve precision, sensitive, significant separation both qualitatively and 
quantitatively. High performance thin layer chromatography (HPTLC) is a valuable 
quality assessment tool for the evaluation of botanical materials efficiently and cost 
effectively. HPTLC method offers high degree of selectivity, sensitivity and rapidity 
combined with single-step sample preparation. In addition it is a reliable method for 
the quantitation of nano grams level of samples. Thus this method can be 
conveniently adopted for routine quality control analysis. It provides chromatographic 
fingerprint of phytochemicals which is suitable for confirming the identity and purity 
of medicinal plant raw materials.  
Chromatogram Development 
It was carried out in CAMAG Twin Trough chambers. Sample elution was 
carried out according to the adsorption capability of the component to be analysed. 
After elution, plates were taken out of the chamber and dried. 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning 
were brought into integration through CAMAG software. Chromatographic finger 
print was developed for the detection of phytoconstituents present in each extract and 
Rf values were tabulated.
 
Reference 
1. Wagner H. Plant Drug Analysis. A thin Layer chromatography Atlas.2nd ed. 








HPTLC Chromatographic condition  
Sample   : OK 
Derivatization Solvent  :Anisaldehyde 
Stationary phase  : Silica gel GF254 
Mobile phase  : Chloroform : n-butanol: methanol: water: 
Acetic   
                                                  acid (4:1:1:0.5:0.5)  
Scanning wavelength  : 366 nm 
Sample concentration  : 10mg/ml  
Applied volume             : 5 µl  





HPTLC CHROMATOGRAM OF OK 
 
 








































STERILITY TEST BY POUR PLATE METHOD 
Objective  
The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated un sterile sample (formulation) when come in contact with the nutrition rich 
medium it promotes the growth of the organism and after stipulated period of incubation the 
growth of the organism was identified by characteristic pattern of colonies. The colonies are 
referred to as Colony Forming Units (CFUs).   
Methodology 
About 1ml of the test sample was inoculated in sterile petri dish to which about 15 mL of 
molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting and 
swirling the dish. Agar was allowed to completely gel without disturbing it. (about 10 
minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. Grown colonies 
of organism was then counted and calculated for CFU.  













No growth / colonies were observed in any of the plates inoculates with the test sample. 
Test Specification Result Method 
E-coli Absent Absent As per AYUSH 
specification Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 























 ICP-MS- Heavy Metal Analysis Report 
ICP-MS 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS): ICP-MS is a type 
of mass spectrometry that is highly sensitive and capable of the determination of a 
range of metals and several non-metals at concentration below one part in 1012 (parts 
per trillion). Samples are decomposed to neutral elements in high temperature argon 
plasma and analyzed based on their mass to charge ratios. It is an automated, simple 
and unique quantitative and qualitative analysis. It measures elemental isotopes ratio. 
Procedure 
Digestion of sample is carried out by transforming 2.5 ml of the sample into a 
closed beaker and 5 ml of concentrated HNO3 was added and digested to near 
dryness. 16 M nitric acid was further added each time to the sample and digested until 
the clear solution was obtained. 5ml of 12 M Hydrochloric acid was added to ensure 
complete digestion .The digested solution was cooled to room temperature and made 
to the final volume of 100 ml with deionized water. Sample solutions were then 
filtered through membrane (0.45micron) filter. Finally, the digested samples were 
used for metal analysis using inductively coupled plasma Mass Spectrometry (Perkin 
Elmer DRC-e Model) .Each sample was digested in triplicate. A blank solution was 





Machine Model: Agilent 7700 ICPMS 
Sample ID: OK 
Element Concentration (mg/L) Upper Limit (mg/L) 




 BDL- Below Detective Level 
Reference 
1. Smille TJ and Khan IA, A Comprehensive approach to Identifying and 
authenticating Botanical Products, Clinical Pharmacology and therapeutics. 2010; 
87(2): 175-186. 
2. Limmatvapirat CJ, Charoenteeraboon, Phaechamud T. Simultaneous analysis of 
eleven heavy metals in extracts of Sonneratia caseolaris (L.) Engl. By ICP-MS. 













TOXICITY STUDY  
  
Project Report on Toxicity Profiling of Oma Kudineer 
 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Oma Kudineer was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 





humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423 1. The animals were fasted overnight with free access to water. The study was 





One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
 
 
Name Dr. D.S.LAVANYA 
IAEC SU/CLATR/IAEC/VII/040/2016 
Name of the Formulation Oma Kudineer 
Abbreviation OK 
Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Oma Kudineer 
2000mg/kg (p.o). The animals were observed continuously for first 72 h and then 14 
days for emerging signs of behavioral changes, body weight changes and for 
mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 











Fecal Pellet Analysis 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean 
and sterile Stainless steel tray. The collected pellets were analyzed for consistency, 




      
 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft  Pasty 
Shape Irregular 
Colour Pale brownish 
Mucous Shedding Absence 
Blood Cells Absent 
Signs  
 
of Infection None Observed 
 Muscle Grip Strength Analysis 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle 
force in vivo. Rats of control and drug treated group was allowed to hold the pull bar 
with both the hind limbs firmly then the animal was gently pulled back with the tail 
until the animal lost the grip toward the bar. The procedure was repeated to get the 
average value. Muscle grip ness of the drug treated group was compared to that of the 
control rat to ensure the change in coordination.  





Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 























Assessment of clinical signs in rats treated with Oma Kudineer on Acute toxicity 
study 
Acute 
Parameter Group I 
Clinical Signs Parameters for the duration of 
14 days Test Drug 2000mg/kg 
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Moderate 
Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behaviour Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behaviour Normal 
Giat Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine Ph 6 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 




Quantitative data on the body weight of rats treated with Oma Kudineer in Acute 
toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 179.5 188.8 
Std. Deviation 4.80 5.776 
Std. Error 1.962 2.358 
 
Values are mean ± S.D (n = 6 per group). Statistical significance carried out using one 
way ANOVA followed by Dunnett’s test. 





Quantitative data on absolute organ weight of rats treated with Oma Kudineer in 
Acute toxicity study 
 
Values are mean ± S.D (n = 6 per females) .Statistically done using one way ANOVA 
followed by Dunnett’s test. 
Reference 
1. OECD Guideline for testing of Chemicals (2001) Guideline 423: Acute Oral 
Toxicity-Acute Toxic Class Method. 












BRAIN   
(gms) 
LUNG    
(gms) 






Mean 0.5917 5.182 1.55 0.7 1.517 1.633 0.8333 1.417 
Std. Deviation 0.1436 1.022 0.1643 0.1549 0.2317 0.2422 0.2875 0.1329 





















 In-vitro Anti-Inflammatory Activity by Protein (Albumin) denaturation Assay 
Project ID  : NRS/AS/0021/01/2017 
Institute   : Govt Siddha Medical College, Chennai, Tamil Nadu, 
India 
Sample Name  : Oma Kudineer 
Sample ID   : OK 
Sample Stock prepared using DD water 
Albumin Denaturation Assay Procedure 
In-vitro anti-inflammatory activity Oma Kudineer (OK) was studied using 
albumin denaturation technique. The reaction mixture consisted of bovine serum 
albumin (5% aqueous solution) and test sample OK at varying concentration ranges 
from 100 to 500 mcg/ml and standard diclofenac sodium at the concentration of100 
mcg/ml of final volume. pH was adjusted by using a small amount of 1N 
Hydrochloric acid. The samples were incubated at 37°C for 20 min and then heated at 
57°C for 3 min. After cooling the sample, 2.5 ml of phosphate buffer solution was 
added into each test tube. Turbidity developed was measured spectrophoto-metrically 
at 660 nm, for control distilled water was used instead of test sample while product 
control tests lacked bovine serum albumin. The experiment was performed in 
triplicate. 
The Percentage protection from denaturation is calculated by using the formulae 
 
Statistical analysis 
Results are expressed as Mean ± SD. The difference between experimental groups 
was compared by One-Way Analysis Of Variance (ANOVA) followed by Dunnet 






Preparation of Test and control 
 
Absorbance of reaction mixture – Test Sample 
 
Absorbance of reaction mixture – Control and Standard 
  
Absorbance Range of test and standard at Trial 1 
 
Absorbance Range of test and standard at Trial 2 
 







0.83  ± 0.01 
PKM 100 0.63  ± 0.05 
PKM 200 0.56  ± 0.05 
PKM 300 0.48  ± 0.07 
PKM 400 0.39  ± 0.08 
PKM 500 0.30  ± 0.05 
Diclofenac sodium                
(100 µg) 
0.017  ± 0.003 
Each value represents the mean ± SD. N=3 
Concentration in 
µg/ml 
Percentage Inhibition of Protein 
Denaturation 
OK 100 
7.823  ± 3.964 
OK 200 16.2  ± 4.058 
OK 300 25.81  ± 6.67 
OK 400 36.99  ± 8.189 
OK 500 
46.93  ± 4.164 
Diclofenac sodium                
(100 µg) 
81.5  ± 1.087 
Each value represents the mean ± SD. N=3 
Result Analysis 
The result obtained from the present clearly indicates that the test drug OK was 
effective in inhibiting heat induced albumin denaturation. Maximum percentage 
inhibition of about 46.93 % was observed at 500 μg/ml when compare to that of the 
Diclofenac sodium, a standard anti-inflammatory agent with the maximum inhibition 
81.5 % at the concentration of 100 μg/ml. 
 
Conclusion 
From the result of the study it was concluded that the test drug OK possess 
Convincing anti-inflammatory property in protein denaturation assay. 
 
Reference 
1. G.Leelaprakash, S.Mohan Dass. In-vitro anti-inflammatory activity of 
methanol extract of enicostemma axillare. Int. J. Drug Dev. & Res., 2011, 3 
(3): 189-196. 
2. M. V. Anoop, A. R. Bindu . In-vitro Anti-inflammatory Activity Studies on 
Syzygium zeylanicum (L.) DC Leaves. International Journal of Pharma 








Purpose: Anti- Microbial Profiling 
Project Id: NRS/AS/0021/01/2017 
Total Sample: 01  
Sample ID: OK 
Institute: Govt Siddha Medical College, Chennai 
Disc-diffusion method:  
The antibacterial activities of the sample OK were carried out by disc 
diffusion method.  The concentrations of the test compounds were used at the 
concentration of 100, 200, 300 µg. The target microorganisms were cultured in 
Mueller–Hinton broth (MHB). After 24 h the suspensions were adjusted to standard 
sub culture dilution. The Petri dishes containing Muller Hinton Agar (MHA) medium 
were cultured with diluted bacterial strain. Disc made of Whatman No.1, diameter 6 
mm was pre-sterilized and was maintained in aseptic chamber. Each concentration 
was injected to the sterile disc papers. Then the prepared discs were placed on the 
culture medium. Standard drug Ciprofloxacin (5µg) was used as a positive reference 
standard to determine the sensitivity of each microbial species tested. Then the 
inoculated plates were incubated at 37
o 
C for 24 h . The diameter of the clear zone 
around the disc was measured and expressed in millimeters as its anti-microbial 
property. The results were depicted in Table. 
Organisms used for Anti-Bacterial Activity 
s.no organisms Type 
7.  Staphylococcus aureus Gram-positive 
8.  Streptococcus pyogenes  Gram-positive 
9.  Klebsiella pneumonia Gram-negative 



























OK - - - - - - - - - 
Ciprofloxacin 
(5µg) 20 28 22 
 -  =  Not active 
 
Conclusion 
From the results of the present study it was concluded that the sample OK was not 
effective against any of the tested organism  
Anti-Bacterial Evaluation of OK 
Anti- Microbial Effect of OK against Klebsiella pneumonia 
 



























































BIO STATICAL ANALYSIS 
 
Treatment for Neer Kana Mantham(Acute Naso Pharyngitis): 
 
       The most popular non parametric statistical tool ,namely, McNemer Test analysis 
has been  employed to analyze the effectiveness with the help of hypothesis 
 
 
S.NO  Clinical Features Before Treatment After Treatment 
     n%       n% 
1 Cough   40(100) 2(5)
* 
2 Running Nose   40(100) 3(7.5)
** 
3 Fever 11(27.5) 1(2.5)
*** 
4 Malaise 4(10) 1(2.5)
**** 
5 Diarrhoea    0(0) 0(0) 
 
Mcnemar’s test : C.I:95%   * P**<0.0001    ***P=0.0020    ****P<0.2500 
 
Software: spss 17.6 version 
 




            Since the p value is significant in all signs and symptoms. So there is 
significant reducing of signs and symptoms among the patients for the treatment of 
Neer kana maantham (Acute Naso pharyngitis). Hence it is concluded that the 






























 GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
 CLINICAL STUDY ON “OMA KUDINEER” IN THE TREATMENT OF   
“NEER KANA MAANTHAM’’ (ACUTE NASO PHARYNGITIS) IN        
CHILDREN. 
FORM l - SCREENING AND SELECTION PROFORMA 
1.OP NO:  ................................................................. 
2. NAME:  ………………………………………….  
3. AGE:      ………       4.GENDER: ………….......  
5. F.OCCUPATION: ………………………………..      6.F.INCOME:   
………………… 
7. ADDRESS:    ……………………………………    
…………………………………… 
…………………………………… 
8. CONTACT NO:    ……………………………………              
 INCLUSION CRITERIA: 
      Age :  2-12 Yrs          
1) Cough                                                                            Yes / No 
2) Running nose                                                                     Yes/No 
3) Fever                                                                                  Yes/No  
4) Malaise                                                                               Yes/No 
5) Diarrhoea                                                                            Yes/No                                                                                              
6) Patients who are willing to undergo Laboratory  investigation. Yes/No                                                                                          
                                                                                      
7) Patients who are willing to sign the informed consent stating that she will 
conscientiously  stick to the treatment during 48days but can opt out of the trial of her 
own conscious discretion.                                   Yes / No 
                




History of  bronchitis 




ADMITTED TO TRIAL: 








Date:        
Station: 
 
Signature of the Guide                                                   Signature of the Investigator   
 
   
 
 





GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106  
CLINICAL STUDY ON ‘OMA KUDINEER” IN THE TREATMENT OF    
“NEER KANA MAANTHAM’’ (ACUTE NASO PHARYNGITIS IN 
CHILDREN) 
FORM lI -HISTORY TAKING PROFORMA 
1. SERIAL NO OF THE CASE: ……. 
2.OP/IP NO: .................................................... 
3. NAME: ………………………………………… 
4. AGE: ……. 
 5. GENDER: …….. 
5.F. OCCUPATION: ……………………………… 
6.F. INCOME:   ………………….. 
7.COMPLAINTS&DURATION:                                                                                                                                      
8.PERSONAL HISTORY: 
9. HISTORY OF PREVIOUS ILLNESS 
10. BIRTH HISTORY 
11. DIETARY HABIT: 
             1.Vegetarian              
             2.Non-vegetarian 
12. FAMILY HISTORY: 
               Whether this problem runs in family? 
                                         1. Yes                               2.No         
               If yes, mention the relationship of affected person(s) --------------------- 
               History of previous investigations if any ------------------------------ 
Date:          
Station                                               
Signature of the Guide                                             Signature of the Investigator 
      
                 
                 GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ONOMA KUDINEER’” IN THE TREATMENT OF  
         “NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS )IN 
CHILDREN 
FORM III ASSESSMENT PROFORMA 
 
1. SERIAL NO: …………………   
2.OP / IP NO: ......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................            
GENERAL EXAMINATION: 
Height (cms)                : ………………………….                   
Weight (kg)    : ………………………….                   
Temperature(°F)     : ………………………….                   
Pulse rate(/min)   : ………………………….                   
Heart rate(/min)   : ………………………….                   
Respiratory rate(/min)  : ………………………….                   
Blood pressure(mm/Hg)       : ………………………….           







Jugular vein pulsation 
 
SYSTEMIC EXAMINATION 
CardioVascular System  : ………………………….                   
 
Respiratory system   : ………………………….                   
 
Gastro-intestinal system  : ………………………….                   
 
Central Nervous System  : ………………………….                   
 
Urogenital system   : ………………………….                   
 
Endocrine System   : ………………………….                   
 
 
SIDDHA SYSTEM OF EXAMINATIONS: 
1. THEGI:  [BODY CONSTITUTION]  
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal        
 
2. NILAM:  [LAND WHERE PATIENT LIVED MOST] 
   1. Kurinji    (Hilly terrain)                                   
   2. Mullai    (Forest range)                       
    3. Marutham    (Plains)                            
4. Neithal     (Coastal belt)                    
     5. Paalai  (Arid regions) 
 
3. KAALAM: 
1. Kaar kaalam                               4.Pinpani kaalam      
2. Koothir kaalam                           5. Ilavenil kaalam 
3. Munpani kaalam                           6.Muthuvenil kaalam 
4. GUNAM: 
           1.Sathuvam                2.Raasatham             3.Thaamatham 
5. IMPORIGAL (SENSORY ORGANS): 
                                                                        Normal/Affected 
Mei     - ----------------------------------------------- 
Vaai       ----------------------------------------------- 
Kann  -------------------------------------------------------- 
Mukku ------------------------------------------------------- 
Sevi ------------------------------------------------ 
6. KANMENDHIRIYAM (MOTOR ORGANS): 
Kai    ----------------------------------                
Kal    ------------------------------------ 
Vaai  ------------------------------------ 
Eruvai  ---------------------------------- 
Karuvaai  --------------------------------- 
 7. KOSANGAL (SHEATH): 
Annamaya kosam ------------------------ 
Pranamaya kosam -------------------------- 
Manomaya kosam ------------------------------- 
Vignana maya kosam ----------------------------- 
Anandamaya kosam ------------------------------- 
 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI,  AZHAL, IYAM) 
A) VALI 































10. ENVAGAI THERVU: 
I. NAADI: [PULSE PERCEPTION]         
II. SPARISAM: [PALPATION] 
III. NAA: [TONGUE] 
 IV.NIRAM: [COMPLEXION]   
    1. Vadham         
     2. Pitham 
      3. Kabam  
 V.MOZHI: [VOICE] 
            1. High Pitched 
            2. Low Pitched 
                        3. Medium Pitched 
          VI.VIZHI: [EYES] 















Date:      
Station: 




 GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF  KUZHANTHAI MARUTHUVAM 
  CLINICAL STUDY ON “OMA KUDINEER”” IN THE TREATMENT OF  
         “NEER KANA MAANTHAM’’ (ACUTE NASO PHARYNGITIS IN 
CHILDREN) 
FORM IV : LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO OF THE CASE: …………………   
2.OP / IP NO: ......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................   
A) BLOOD INVESTIGATIONS:                        




Hb ( gm/dL)   
Absolute eosinophil count ( Cells/ul)   
ESR (mm) ½ hr.   
  
1 hr.   
T.WBC (Cells / Cu.mm)   
Differential 
Count (%) 
Polymorphs   
  
Lymphocytes   
  
Monocytes   
  
Eosinophils   
  









Motion Ova   
  
Cyst   
  
Occult blood   
 
   
B) URINE INVESTIGATIONS: 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
Albumin   
          Sugar   




Date:          
Station: 
 Signature of the Guide  




                    
                   GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “OMA KUDINEER” IN THE TREATMENT OF   
’’NEER KANA MAANTHAM’’ (ACUTE NASO PHARYNGITIS IN 
CHILDREN)  
FORM V: INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have asked have 
been answered to my satisfaction. 
            I   consent voluntarily to participate my chid in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my chid further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
that the individual has given consent freely.”                                                   
Date: 
 Signature of a witness                                            Left thumb Impression of the 
Participant     
(Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                   
Signature of the Guide:                                                Signature of the Investigator:   
 
      
             
                 GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI 
  CLINICAL STUDY ON “OMA KUDINEER” IN THE TREATMENT OF  
         NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS IN 
CHILDREN) 
  FORM VI - WITHDRAWAL FORM 
SI NO:                 
OP / IP NO:                                               
NAME: 
AGE / GENDER :                
DATE OF TRIAL COMMENCEMENT: 
DATE OF WITHDRAWAL FROM TRIAL: 
REASONS FOR WITHDRAWAL: 
• Long absence at reporting :                                    Yes/ No 
• Irregular treatment:                                                Yes/ No 
• Shift of locality :                                                    Yes/No 
• Increase in severity of symptoms:                         Yes/No 
• Development of severe adverse drug reactions:    Yes/No 
 
 
Date:          
Station: 




                        
                     GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
  CLINICAL STUDY ON “OMA KUDINEER” IN THE TREATMENT OF  
         “NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS IN 
CHILDREN) 
 
                               FORM VII – PATIENT INFORMATION SHEET 
Name of Co- Investigator: D.S.LAVANYA           Name of the college:  
                                                                                Govt.Siddha Medical  College 
                                                                                Arumbakkam 
                                                                        Chennai-106. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
       I,D.S.LAVANYA  studying M.D (Siddha) at Govt.Siddha Medical College, 
Chennai,  is doing a clinical trial on ‘’ OMA KUDINEER” IN THE TREATMENT 
OF  
NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS IN CHILDREN) 
 
  . It is becoming a most common disease, occurring throughout the world. In this 
regard, I am in need to ask you few questions. I will maintain confidentiality of your 
comments and data obtained. There will be no risk of disclosing your identity and no 
physical, psychological or professional risk is involved by taking part in this study. 
Taking part in this study is voluntary. No compensation will be paid to you for  taking  
part in this study. 
           You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
        If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal 
medicine‘‘OMA KUDINEER’’ for-7 days  
  The information I am collecting in this study will remain between you and the 
Co- investigator (myself). I will ask you few questions through a questionnaire. I will 
not write your name on this form. I will use a code instead. 
The questionnaire will take approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask 
me all the questions you want or contact D.S.Lavanya, PG Scholar cum Co- 
investigator of this study, attached to Govt. Siddha Medical College, Chennai-106. 
You can also contact the Member-secretary of Ethics committee, Govt.Siddha 
Medical College, Chennai. 
 











                 
                       
                           GOVERNMENT SIDDHA MEDICAL COLLEGE
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “OMA KUDINEER” IN THE TREATMENT OF  
         “NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS IN 
CHILDREN 
FORM X - ADVERSE REACTION REPORTING FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                    AGE:                                          GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:  TIME: 







Date:                                                                              
Station: 
Signature of the Guide                                                  Signature of the Investigator   
 
   
            
  GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL CHENNAI 
                         Branch -IV KUZHANTHAI MARUTHUVAM 
            PROFORMA OF CASE SHEET FOR NEER KANA MANTHAM 
OP. No :                                                                                       Nationality : 
Name :                                                                                          Religion : 
Age :                                                                                            Date of Admission : 
Sex   :                                                                                          Date of Discharge : 
Address :                                                                                     Diagnosis : 
Informant :                                                                                Medical Officer : 
1. Complaints and duration : 
2. History of present illness : 
3. History of Past illness : 
4. Antenatal history : 
5. Birth history : 
6. Neonatal history : 
7. Developmental history : 
8. Nutritional history : 
9. Immunization history : 
10. Family history : 
11. Socio economic status : 
General examination 
1. Appearance and posture : 
2. Nutritional status : 
3. Anaemia : 
4. Cyanosis : 
5. Clubbing : 
6. Jaundice : 
7. Lymphadenopathy : 
8. Abdominal distension : 
9. Pedal oedema : 
Vital Signs 
1. Temperature : 
2. Pulse rate : 
3. Respiratory rate : 
4. Heart rate : 
5. Blood pressure : 
Anthropometry 
a. Height : 
b. Weight : 
c .Chest circumference : 
SIDDHA ASPECT 
Nilam 
1. Kurinji : 
2. Mullai : 
3. Marutham : 
4. Neithal : 
5. Paalai : 
Paruvakaalam 
1. Kaar : 
2. Koothir : 
3. Munpani : 
4. Pinpani : 
5. Elavenil : 
6. Muthuvenil : 
Poripulangal 
1. Mei : 
2. Vai : 
3. Kan : 
4. Mooku : 
5. Sevi : 
Kanmenthiriyam 
1. Kai : 
2. Kaal : 
3. Vaai : 
4. Eruvai : 
5. Karuvai : 
Uyir thathukkal 
Vadham 
1. Praanan : 
2. Abaanan : 
3. Viyaanan : 
4. Uthaanan : 
5. Samaanan : 
6. Naagan : 
7. Koorman : 
8. Kirukaran : 
9. Devathathan : 
10. Dhananjeyan : 
Pitham 
1. Analpitham : 
2. Ranjagam : 
3. Saadhagam : 
4. Praasagam : 
5. Aalosagam : 
Kabam 
1. Avalambagam : 
2. Kiletham : 
3. Pothagam : 
4. Tharpagam : 
5. Santhigam : 
Udar kattugal 
1. Saaram : 
2. Senneer : 
3. Oonn : 
4. Kozhuppu : 
5. Enbu : 
6. Moolai : 
7. Sukkilam / Suronitham: 
Envagai thervugal 
1. Naadi : 
2. Sparisam : 
3. Naa : 
4. Niram : 
5. Mozhi : 
6. Vizhi : 
7. Malam : 
8. Moothiram : 
MODERN ASPECTS 
1. Respiratory System : 
2. Cardiovascular system : 
3. Gastro intestinal system : 
4. Central nervous system : 






1/2 hr : 















Date Symptoms Medicine 
   
   
   
   
   
 
  
                                   அரசு சித்ை மருத்துவக் கல்லூரி, வசன்தன-106 
                   அறிஞர் அண்ைா மருத்துவமதன, வசன்தன. 
            ீர்க்கை மாந்ைம் ந ாய்க்கான் சித்ை மருத்ைின் (ஓமக்குடி ீர்)  
பரிகரிப்புத் ைிறதனக் கண்டறியும் மருத்துவ ஆய்விற்கான் ைகவல் படிவம். 
ஒப்புைல் படிவம் ஆய்வாளரால் சான்றளிக்கப்பட்டது 
      ான் இந்ை ஆய்தவ குறித்ை அதனத்து விபரங்கதளயும் ந ாயாளிக்கு 
புரியும் வதகயில் எடுத்துதரத்நைன் என உறுைியளிக்கிநறன். 
நைைி:                          தகவயாப்பம்: 
இடம்:                         வபயர்: 
ந ாயாளியின் வபற்நறார் ஒப்புைல் படிவம் 
என்னிடம் இந்ை மருத்துவ ஆய்வின் காரைத்தையும், மருந்ைின் ைன்தம 
மற்றும் மருத்துவ வழிமுதற பற்றியும், வைாடர்ந்து எனது உடல் 
இயக்கத்தை கண்காைிக்கவும், அைதன பாதுகாக்கவும் பயன்படும் 
மருத்துவ ஆய்வுக்கூட பரிநசாைதனகள் பற்றி ைிருப்ைி அளிக்கும் வதகயில் 
ஆய்வு மருத்துவரால் விளக்கிக் கூறப்பட்டது. 
 ான் எனது குழந்தையின் இந்ை மருத்துவ ஆய்வின் நபாது, காரைம் 
எதுவும் கூறாமல், எப்வபாழுத்ய நவண்டுமானாலும் இந்ை ஆய்விலிருந்து 
எனது குழந்தையின் விடுவித்து வகாள்ளும் உரிதமதய 
வைரிந்ைிருக்கின்நறன்.  ான் என்னுதடய சுைந்ைிரமாக நைர்வு வசய்யும் 
உரிதமதயக் வகாண்டு ந ாய்க்கான ஓமக்குடி ீர் மருந்ைின் பரிகரிப்புத் 
ைிறதனக் கண்டறியும் மருத்துவ ஆய்விற்கு என்தன உட்படுத்ை ஒப்புைல் 
அளிக்கிநறன். 
நைைி:                        தகவயாப்பம்: 
இடம்:                       வபயர்: 
நைைி:                        சாட்சிக்காரர் தகவயாப்பம்: 
இடம்:                       வபயர்: 
உறவுமுதற 











                அரசு சித்ை மருத்துவக் கல்லூரி, வசன்தன-106 
                அறிஞர் அண்ைா மருத்துவமதன, வசன்தன. 
 ீர்க்கை மாந்ைம் ந ாய்க்கான் சித்ை மருத்ைின் (ஓமக்குடி ீர்)  
பரிகரிப்புத் ைிறதனக் கண்டறியும் மருத்துவ ஆய்விற்கான் ைகவல் படிவம். 
 
ஆராய்ச்சியாளர் வபயர் : ைா.ச.லாவண்யா 
 ிறுவனத்ைின் வபயர் : அரசு சித்ை மருத்துவக் கல்லூரி 
                        அரும்பாக்கம், வசன்தன-106. 
 
அரசு சித்ை மருத்துவக் கல்லூரியில் பட்ட நமற்படிப்பு பயின்று வரும்  ான் 
மருத்துவர். ைாச.லாவண்யா.  ீர்க்கை மாந்ைம்  என்னும் ந ாயில் மருத்துவ 
ஆராய்ச்சியில் ஈடுபட்டுள்நளன். 
        இந்ை ந ாய் கிருமிகளினால் எற்படுகின்றன. இது பரவக் 
கூடியந ாய். 
 இந்ை ஆராய்ச்சி சம்பந்ைமாக சில நகள்விகதளக் நகட்கவும், நைதவயான் 
ஆய்வகப் பரிநசாைதனக்கு ைங்கதள உட்படுத்ைவும் உள்நளன். 
   இந்ை ஆராய்ச்சிக்கு ைங்கள் விருப்பத்ைின் நபரில் உட்படும் பட்சத்ைில் 
உள்மருந்ைாக ஓமக்குடி ீர்  2நவதள(காதல, மாதல) உைவுக்கு பின் 7 
 ாட்கள் உட்வகாள்ள  நவண்டும். 
        இந்ை மருந்து சிறப்பாக  ீர்க்கை மாந்ைம் 
ந ாய்க்காஅங்கீகரிக்கப்பட்ட சித்ை மருத்துவ நூலில் கூறப்பட்டுள்ளது. 
        இந்ை ஆராய்ச்சியில் ைங்கதள அனுமைித்ை பிறகு உங்களுக்கு 
விருப்பம் இல்தலவயனில் எப்நபாது நவண்டுமானாலும் ஆராய்ச்சியில் 
இருந்து விலகிக் வகாள்ள உரிதம உள்ளது. 
        இந்ை  ஆராய்ச்சி சம்பந்ைமாக ந ாயின் ைன்தம பற்றியும் மற்ற 
விபரங்களுக்கும் ஆராய்ச்சியாளர் மருத்துவர் : ைா.ச.லாவண்யா (பட்ட நமற் 
படிப்பாளர் குழந்தை மருத்துவ துதற) அவர்கதள எந்ை ந ரத்ைிலும் 
வைாடர்பு வகாள்ளலாஅம் தகப்நபசி எண் : 9176126948 
     நமலும் இந்ை ஆராய்ச்சிக்கு ைக்க அனுமைிச் சான்று( IEC ) 
வபறப்பட்டுள்ளது 
     இந்ை மருந்து முற்றிலும் பாதுகாப்பான மூலிதக வபாருட்கதளக் 
வகாண்டு ையாரிக்கப்பட்டுள்ளது. பக்க விதளவுகதள ஏற்படுத்ைாது. 
     நமலும் உைவு முதறயில் மருத்துவரால் கூறப்படும் பத்ைியம் 
காக்குமாறு அறிவுறுத்ை படுகிறது. 
    இது சம்பந்ைமான ைங்களது அதனத்து விவரங்களும் ரகசியமாக 
தவக்கப்படும் என உறுைி அளிக்கிநறன். 
    இைில் பயைப்படி முைலிய எந்ை உைவித் வைாதகயும் வழங்கப் பட 
மாட்டாது. 
        இந்ை ஆராய்ச்சியின் நபாது உடலுக்கு நவறு பாைிப்பு ஏற்படும் 










                                 Department of PG Kuzhanthai  Maruthuvam 
                           Dissertation study on NEER KANA MAANTHAM 
   Guide:Dr.S.Gandhimathi MD(s)                                                   Investigator:Dr.D.S.Lavanya PG Scholar 
                         Aringar Anna hospital OPD,Chennai-106 
 
 
NAME  OP.NO  
AGE/SEX  DATE  















                                        COMPLAINTS AND DURATION 
a)cough Yes                 No 
b)Runningnose         Yes                 No 
c)Fever Yes                 No 
d)Malaise Yes                No 
e)Diarrhoea Yes                No 
Other complaints 
 
                                                   PAST HISTORY 
 
FAMILIAL HISTORY  
MODE OF ONSET     Acute              Chronic    
FOOD HABITS     Veg                  Non-veg 
ECONOMIC STATUS      Poor                 middle                rich 









                                      Department of PG Kuzhanthai Maruthuvam 
       Dissertation study on NEER KANA MAANTHAM with evaluation of OMA KUDINEER 
Guide:Dr.S.Gandhimathi ,MD(s) Investigaor:Dr.D.S.Lavanya ,PG scholar 
                                         Aringar Anna hospital OPD,Chennai-106 









                                                                INVESTIGATION 
Before 
treatment 
 After treatment 
Blood  Blood  
TC  TC  
DC  DC  
ESR  ESR  
HB  HB  
Others  Others  
MEDICINE    
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